1. Home
  2. NSYS vs BOLD Comparison

NSYS vs BOLD Comparison

Compare NSYS & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$13.45

Market Cap

25.6M

Sector

Technology

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.15

Market Cap

25.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
BOLD
Founded
1981
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
25.6M
25.7M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
NSYS
BOLD
Price
$13.45
$1.15
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
18.7K
85.8K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
80.85
32.47
EPS
N/A
N/A
Revenue
$14,371,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.50
$0.96
52 Week High
$13.36
$1.78

Technical Indicators

Market Signals
Indicator
NSYS
BOLD
Relative Strength Index (RSI) 81.26 52.02
Support Level $8.40 $1.11
Resistance Level N/A $1.20
Average True Range (ATR) 0.58 0.05
MACD 0.28 0.00
Stochastic Oscillator 93.67 53.33

Price Performance

Historical Comparison
NSYS
BOLD

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: